Nikhil Prasad Fact checked by:Thailand Medical News Team Jul 30, 2026 33 minutes ago
Medical News: Scientists Uncover Lipid Signals That Can Either Worsen or Protect Against Deadly Sepsis
Sepsis remains one of the world's deadliest medical emergencies, developing when the body's response to an infection spirals out of control and begins attacking its own organs. Now, researchers have uncovered compelling evidence that naturally occurring fat-derived molecules known as arachidonic acid metabolites may play a decisive role in determining whether patients recover or suffer life-threatening organ failure.
Scientists identify key arachidonic acid metabolites that can either worsen sepsis or help protect
vital organs, opening new avenues for targeted therapies.
The review was conducted by researchers from the Department of Emergency Medicine, Second Xiangya Hospital, Central South University, the Department of Geriatric Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, and the Department of Emergency Medicine, Guilin Hospital of The Second Xiangya Hospital, Central South University, all in China.
Tiny Fat Molecules with Huge Effects
Arachidonic acid is a fatty acid stored within the membranes of nearly every cell in the body. During infections or inflammation, it is released and converted into a wide range of signaling molecules through three major pathways known as COX, LOX, and CYP. These compounds help regulate inflammation, blood flow, immune responses, and tissue repair.
However, the researchers found that this system becomes severely disrupted during sepsis. Some metabolites, including prostaglandin E2 (PGE2), leukotriene B4 (LTB4), thromboxane A2 (TXA2), and certain HETE compounds, can intensify inflammation, increase blood vessel leakage, promote oxidative stress, and damage organs. Others, including lipoxin A4 (LXA4) and epoxyeicosatrienoic acids (EETs), help calm excessive inflammation, improve blood circulation, and support tissue recovery.
How Organ Damage Develops
This
Medical News report highlights that the balance between harmful and protective metabolites appears to determine how severely sepsis affects the heart, lungs, liver, and kidneys.
In the heart, excessive LTB4 promotes inflammation, mitochondrial dysfunction, and weakening of the heart muscle. In contrast, EETs and 20-HETE may protect heart cells by reducing inflammation and preventing cell death.
Within the lungs, elevated TXA2 and LTB4 increase blood vessel leakage, worsen oxygen exchange, and encourage inflammatory cells to invade lung tissue, raising the risk of acute respiratory distress syndrome. Protective molecules such as EETs may reduce these damaging effects by preserving healthy blood vessel function.
The liver also experiences major metabolic changes. Increased levels of inflammatory molecules like 12-HETE and 20-HETE activate pathways that boost inflammatory cytokines and oxidative damage. Stabilizing EETs using soluble epoxide hydrolase inhibitors reduced liver inflammation and promoted immune regulation in experimental studies.
The
kidneys are similarly affected. Harmful metabolites narrow blood vessels supplying the kidneys, reducing blood flow and contributing to acute kidney injury. Meanwhile, protective metabolites help maintain kidney circulation and reduce inflammation, potentially preserving kidney function during severe infection.
New Treatment Possibilities
The researchers believe these discoveries could eventually transform sepsis treatment. Instead of simply suppressing the immune system, future therapies may selectively block harmful metabolites while preserving or boosting beneficial ones.
Several experimental approaches have already shown encouraging results in laboratory models. These include inhibiting COX-2 and 5-LOX enzymes, blocking leukotriene signaling, and preventing the breakdown of protective EETs through soluble epoxide hydrolase inhibitors. These strategies consistently reduced inflammation, limited organ damage, and improved survival in animal studies.
Even so, the scientists stress that nearly all current evidence comes from laboratory and preclinical research. Large human clinical trials are still needed before these approaches can become standard medical treatments.
Conclusion
The findings suggest that arachidonic acid metabolism functions as a critical control center during sepsis, influencing whether inflammation spirals into widespread organ failure or begins to resolve. Although much work remains before these discoveries reach hospitals, targeting specific lipid pathways offers one of the most promising directions for developing more precise, personalized treatments that could reduce deaths and improve recovery in patients with sepsis.
The study findings were published in the peer reviewed journal: Drug Design, Development and Therapy.
https://www.tandfonline.com/doi/full/10.2147/DDDT.S623143
For the latest research on sepsis, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/sepsis
Share
Tweet
Share
